1. Abrosch F, Glück R, Herzog C. Clinical and immunological studies with a new virosome-based hepatitis A vaccine. In: Proceeding of 2nd European Congress on Tropical Medicines, Liverpool; 1998.
2. Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial;Holzer;Vaccine,1996
3. Bevier P, Farinelli T, Loutan L, Herzog C, Glück R. Long-term immunogenicity following immunization with a virosome hepatitis A vaccine. Abstracts of 5th International Conference on Travel Medicines, Geneva; 1997 [abstract no. 127].
4. Mayorga O, Egger M, Zellmeyer M, Glück R, Herzog C, Frösner G. Efficacy of a virosome formulated hepatitis A vaccine in an endemic region in Nicaragua: a randomized plazebo-controlled trial. Abstract of 37th ICAAC, Toronto; 1997 [abstract no. H-4].
5. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients;Conne;Vaccine,1997